Altimmune Q2 EPS $(0.60) Up From $(0.94) YoY, Sales $137.62K Down From $721.64K YoY
Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.60) per share. This is a 36.17 percent increase over losses of $(0.94) per share from the same period last year. The company reported $137.62 thousand in sales
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
Analyzing Altimmune’s Unusual Options Activity
On Tuesday, shares of Altimmune (NASDAQ:ALT) saw unusual options activity. After the option alert, the stock price moved up to $9.72.
Altimmune Granted U.S. Patent Titled ‘Antigen delivery vectors and constructs’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5568&f=G&l=50&d=PTXT&p=112&S1=20210720&OS=20210720&RS=20210720
Cramer Gives His Opinion On AT&T, Cemex And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is not a fan of AT&T Inc. (NYSE: T).
Understanding Altimmune’s Unusual Options Activity
Altimmune (NASDAQ:ALT) shares experienced unusual options activity on Thursday. The stock price moved up to $8.78 following the option alert.
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year.
72 Biggest Movers From Yesterday
Gainers
Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share.